Product analysis
Alpha GPC 300 mg offers a choline source with limited evidence for selected attention tasks. Its unspecified preparation makes it hard to compare directly with the products used for those findings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The alpha-GPC preparation is not identified in detail. Its specific form quality therefore remains uncertain.
Ingredient Transparency63
The amount is stated, but the preparation is unspecified. You can compare serving amounts, though not the form in detail.
Value For Money100
The alpha-GPC offers very good value for the amount provided. Its cost compares favorably with a comparable alpha-GPC serving.
Customer Satisfaction83
Customer ratings are very positive. Thousands of ratings give the feedback a substantial base.
Product Focus51
The formula stays focused on a choline source involved in attention-related signalling. Evidence concerns selected tasks and preparations, leaving dependable memory or everyday focus gains uncertain.
- Format
Capsule - Container
- 60 Veggie Cap(s)
- Per serving
- $0.32
- Customer rating
- 4.6 · 2,848 ratings
Goals
Impact
Lower effect
Alpha-GPC · 300 mg
Impact
Moderate effect
Alpha-GPC · 300 mg
Alpha-GPC is a choline source related to acetylcholine, a messenger involved in attention and memory. The 300 mg serving offers a partial amount compared with the supplied reference range; the evidence is limited to specific attention tasks and preparations.
How this product is rated for Brain Health
Ingredient fit74
The relevant ingredients fit the goal, with the declared amounts and broader formula focus shaping their contribution.
Goal fit
The relevant ingredients give the formula a clear connection to brain health.
Dose adequacy
The assessed amounts provide partial support within the supplied comparison range.
Pathways10
The main assessed contribution is concentrated in acetylcholine signalling.
Depth
The strongest saved finding concerns acetylcholine signalling, with partial coverage.
Breadth
The saved findings remain narrow and do not show strong coverage across several brain-health processes.
Evidence35
Alpha-GPC has limited evidence for specific attention tasks. The assessed preparation is not identified as the specific material used in the supporting trials.
Evidence strength
Alpha-GPC has limited evidence for specific attention tasks.
Studied preparation
The assessed preparation is not identified as the specific material used in the supporting trials.
Formulation logic100
The assessed ingredients need no additional partner, and no configured conflicts were found.
Partner coverage
The assessed ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
The ingredients included in this saved finding meet its amount threshold.
Impact
Lower effect
Alpha-GPC · 300 mg
Impact
Moderate effect
Alpha-GPC · 300 mg
Alpha-GPC relates to acetylcholine signalling, which is involved in attention. The 300 mg declaration is close to the lower active amount tested in a small acute trial, but preparation identity and active content affect the comparison. Evidence concerns selected attention tasks around exercise rather than a general promise of better memory.
How this product is rated for Cognitive Support
Ingredient fit91
1 relevant ingredient contribute to the goal, with no other assessed active ingredients reducing the focus. The assessed amounts are close to the full comparison amounts used in the saved findings.
Goal fit
1 relevant ingredient contribute to the goal, with no other assessed active ingredients reducing the focus.
Dose adequacy
The assessed amounts are close to the full comparison amounts used in the saved findings.
Pathways17
The clearest connection is acetylcholine signalling, with a limited contribution in the saved findings.
Depth
The clearest connection is acetylcholine signalling, with a limited contribution in the saved findings.
Breadth
Support remains too limited to show meaningful breadth across the assessed cognitive pathways.
Evidence28
Alpha-GPC provides the strongest evidence contribution at an assessed amount, with benefits limited to the populations and outcomes described in the supplied evidence. Alpha-GPC is not matched to the preparations used in the relevant trials, which limits how directly those findings apply.
Evidence strength
Alpha-GPC provides the strongest evidence contribution at an assessed amount, with benefits limited to the populations and outcomes described in the supplied evidence.
Studied preparation
Alpha-GPC is not matched to the preparations used in the relevant trials, which limits how directly those findings apply.
Formulation logic100
No conflict was identified in the supplied checks. 1 of 1 relevant ingredients meet the saved minimum amount criterion.
Partner coverage
The relevant ingredients can contribute alone or have the partners required by the saved findings.
Conflicts
No conflict was identified in the supplied checks.
Effective doses
1 of 1 relevant ingredients meet the saved minimum amount criterion.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
L-Alpha-Glycerylphosphorylcholine | 300 mg |
Alpha-GPC · 300 mg OverallScore68
Each serving provides 300 mg of Alpha-GPC. Based on the whole-product price, 300 mg of Alpha-GPC works out to about $0.32, a low price in this comparison.
How this ingredient is rated
Active Ingredient Quality & Bioavailability40
The saved facts identify Alpha-GPC without a branded or botanical source.
Patented/Branded Form and Source
Alpha-GPC is named, but the saved facts do not identify a branded or botanical source.
Dose, Safety & Label Transparency80
A serving provides 300 mg of active Alpha-GPC.
Active Alpha-GPC Dosage
A serving provides 300 mg of active Alpha-GPC.
Label Transparency & Yield Disclosure
The active Alpha-GPC amount is given as 300 mg per serving; no separate active-yield statement appears in the saved facts.
Value100
Based on the whole-product price, 300 mg of Alpha-GPC works out to about $0.32, a low price in this comparison.
Price per 300mg Active Alpha-GPC
Based on the whole-product price, 300 mg of Alpha-GPC works out to about $0.32, a low price in this comparison.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Treatment of dementia with neurotransmission modulation.